CEO
Esperion Therapeutics, Inc.
Equibles does not estimate personal net worth.
Timothy Mayleben is recorded as CEO at Esperion Therapeutics, Inc.. Timothy Mayleben has spoken on 1 earnings call across 1 company, most recently for Esperion Therapeutics, Inc. on May 4, 2021. Esperion Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Thank you for joining us today as we review the progress made across our global business during the first quarter. I’ll start today’s call with a brief overview of our progress, touching on the highlights from the quarter.”
Esperion Therapeutics, Inc.
CEO
Source not stated
Esperion Therapeutics, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Esperion Therapeutics, Inc. Q1 FY2021 Earnings Call
Esperion Therapeutics, Inc.
